DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $2,168,000 | +81.4% | 377,000 | 0.0% | 0.12% | +66.2% |
| Q2 2017 | $1,195,000 | -6.8% | 377,000 | 0.0% | 0.07% | -12.9% |
| Q1 2017 | $1,282,000 | +18.0% | 377,000 | 0.0% | 0.08% | +19.7% |
| Q4 2016 | $1,086,000 | -51.0% | 377,000 | 0.0% | 0.07% | -47.4% |
| Q3 2016 | $2,217,000 | +96.0% | 377,000 | 0.0% | 0.14% | +95.7% |
| Q2 2016 | $1,131,000 | -44.0% | 377,000 | 0.0% | 0.07% | -38.9% |
| Q1 2016 | $2,021,000 | -54.8% | 377,000 | 0.0% | 0.11% | -49.6% |
| Q4 2015 | $4,475,000 | +72.8% | 377,000 | +19.6% | 0.22% | +49.3% |
| Q3 2015 | $2,589,000 | -32.6% | 315,300 | +14.5% | 0.15% | -27.9% |
| Q2 2015 | $3,840,000 | +12.4% | 275,300 | +93.7% | 0.21% | -19.1% |
| Q1 2015 | $3,415,000 | +147.6% | 142,100 | +69.8% | 0.26% | +70.2% |
| Q4 2014 | $1,379,000 | +70.0% | 83,700 | +31.4% | 0.15% | +33.6% |
| Q3 2014 | $811,000 | -43.6% | 63,700 | 0.0% | 0.11% | -42.3% |
| Q2 2014 | $1,438,000 | – | 63,700 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,813,392 | $67,676,000 | 17.58% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $114,954,000 | 7.53% |
| RTW INVESTMENTS, LP | 7,521,859 | $280,716,000 | 4.24% |
| DAFNA Capital Management LLC | 510,756 | $19,061,000 | 3.99% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 229,892 | $8,580,000 | 3.83% |
| Parkman Healthcare Partners LLC | 304,686 | $11,371,000 | 2.49% |
| Evolutionary Tree Capital Management, LLC | 141,324 | $5,274,000 | 2.43% |
| Eagle Health Investments LP | 161,125 | $6,013,000 | 2.06% |
| Lombard Odier Asset Management (Switzerland) SA | 636,011 | $23,736,000 | 1.20% |
| Woodline Partners LP | 1,000,325 | $37,332,000 | 0.70% |